Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model
- PMID: 18773495
- DOI: 10.1002/dvdy.21648
Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model
Erratum in
- Dev Dyn. 2009 Nov;238(11):2949
Abstract
Apert syndrome (AS) is a severe congenital disease caused by mutations in fibroblast growth factor receptor-2 (FGFR2), and characterised by craniofacial, limb, visceral, and neural abnormalities. AS-type FGFR2 molecules exert a gain-of-function effect in a ligand-dependent manner, but the causative FGFs and their relative contribution to each of the abnormalities observed in AS remains unknown. We have generated mice that harbour an AS mutation but are deficient in or heterozygous for Fgf10. The genetic knockdown of Fgf10 can rescue the skeletal as well as some of the visceral defects observed in this AS model, and restore a near normal level of FgfR2 signaling involving an apparent switch between ERK(p44/p42) and p38 phosphorylation. Surprisingly, it can also yield de novo cleft palate and blind colon in a subset of the compound mutants. These findings strongly suggest that Fgf10 contributes to AS-like pathologies and highlight a complexity of Fgf10 function in different tissues.
Similar articles
-
Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.J Cell Physiol. 2012 Sep;227(9):3267-77. doi: 10.1002/jcp.24021. J Cell Physiol. 2012. PMID: 22105374
-
Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.BMC Dev Biol. 2010 Feb 22;10:22. doi: 10.1186/1471-213X-10-22. BMC Dev Biol. 2010. PMID: 20175913 Free PMC article.
-
Cell Type-Dependent Nonspecific Fibroblast Growth Factor Signaling in Apert Syndrome.Stem Cells Dev. 2016 Aug 15;25(16):1249-60. doi: 10.1089/scd.2016.0018. Epub 2016 Jun 23. Stem Cells Dev. 2016. PMID: 27339175
-
Fgf10: a paracrine-signaling molecule in development, disease, and regenerative medicine.Curr Mol Med. 2014 May;14(4):504-9. doi: 10.2174/1566524014666140414204829. Curr Mol Med. 2014. PMID: 24730525 Review.
-
FGFs, their receptors, and human limb malformations: clinical and molecular correlations.Am J Med Genet. 2002 Oct 15;112(3):266-78. doi: 10.1002/ajmg.10775. Am J Med Genet. 2002. PMID: 12357470 Review.
Cited by
-
RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1.Elife. 2020 Jul 14;9:e55829. doi: 10.7554/eLife.55829. Elife. 2020. PMID: 32662771 Free PMC article.
-
Palatal and oral manifestations of Muenke syndrome (FGFR3-related craniosynostosis).J Craniofac Surg. 2012 May;23(3):664-8. doi: 10.1097/SCS.0b013e31824db8bb. J Craniofac Surg. 2012. PMID: 22565872 Free PMC article. Review.
-
Differential gene expression of human keratinocyte HaCaT cells induced by fibroblast growth factor 10 treatment.Mol Cell Biochem. 2010 Sep;342(1-2):71-85. doi: 10.1007/s11010-010-0470-1. Epub 2010 May 13. Mol Cell Biochem. 2010. PMID: 20464455
-
Mesodermal Tbx1 is required for patterning the proximal mandible in mice.Dev Biol. 2010 Aug 15;344(2):669-81. doi: 10.1016/j.ydbio.2010.05.496. Epub 2010 May 23. Dev Biol. 2010. PMID: 20501333 Free PMC article.
-
Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10.Bone Rep. 2023 May 26;18:101692. doi: 10.1016/j.bonr.2023.101692. eCollection 2023 Jun. Bone Rep. 2023. PMID: 37275784 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
